Targeted Medical Pharma, Inc.: 10-Q filed 2013-08-14
What Targeted Medical Pharma, Inc. reported in its quarterly report filed 2013-08-14 (fiscal Q2 2013): 35 published measures, 94 facts as tagged in accession 0001144204-13-045999.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-14
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001144204-13-045999 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Targeted Medical Pharma, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 5,066,779 | USD | |
| At 2012-12-31 | 10,628,747 | USD | |
| At 2012-06-30 | 11,219,550 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 12,737,696 | USD | |
| At 2012-12-31 | 12,630,783 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -7,670,917 | USD | |
| At 2012-12-31 | -2,002,036 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 25,949 | USD | |
| At 2012-12-31 | 326,603 | USD | |
| At 2012-06-30 | 44,603 | USD | |
| At 2011-12-31 | 147,364 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -7,841,965 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -8,112,242 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -2,824,823 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -3,800,740 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -290,133 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -2,759,083 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 23,481 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 108,923 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 1,917,388 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 4,728,519 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 1,448,226 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,823,411 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 115,703 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 2,867,500 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -126,224 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -211,178 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -21,797,030 | USD | |
| At 2012-12-31 | -13,684,789 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 5,905,147 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 5,665,624 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -739,056 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,410,146 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 293,552 | USD | |
| At 2012-12-31 | 340,096 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 405,712 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 389,032 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,818,059 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -2,326,320 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -1,697,061 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -3,268,229 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,363,777 | USD | |
| At 2012-12-31 | 2,529,165 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 0 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 12,537,696 | USD | |
| At 2012-12-31 | 12,245,074 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 312,034 | USD | |
| At 2012-12-31 | 353,993 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 2,999,977 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 5,420,695 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 2,524,027 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 4,835,645 | USD | 182 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 703,864 | USD | |
| At 2012-12-31 | 478,499 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 1,181,918 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 3,094,375 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 826,966 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,567,416 | USD | 182 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 2,965,944 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 5,354,582 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 2,494,018 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 4,778,372 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 34,033 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 66,113 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 30,009 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 57,273 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 23,008,782 | shares | |
| At 2012-12-31 | 23,008,782 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 14,102,229 | USD | |
| At 2012-12-31 | 11,659,744 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,286,403 | USD | |
| At 2012-12-31 | 2,318,619 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 0 | USD | |
| At 2012-12-31 | 26,679 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -7,841,965 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -8,112,242 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -2,824,823 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -3,800,740 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 204,984 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 223,291 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -118,759 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -120,298 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -1,866,818 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,942,657 | USD | 182 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 745,679 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -985,202 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -1,410,146 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -41,959 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -331,191 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 225,365 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 644,814 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -309,828 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 861,902 | USD | 182 |
Inspect the source
- Entity
- Targeted Medical Pharma, Inc. / CIK 0001420030
- Captured
- SEC response SHA-256
ca03716eae22460fbd50b309d17f5dd90795ea400593e50d5768fd8934ffb155
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001420030.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))